The c-Abl protein tyrosine kinase is activated by ionizing radiation (IR) and certain other DNA-damaging agents. The present studies demonstrate that c-Abl associates constitutively with protein kinase C d (PKCd). The results show that the SH3 domain of c-Abl interacts directly with PKCd. c-Abl phosphorylates and activates PKCd in vitro. We also show that IR treatment of cells is associated with c-Abl-dependent phosphorylation of PKCd and translocation of PKCd to the nucleus. These ®ndings support a functional interaction between c-Abl and PKCd in the cellular response to genotoxic stress.
Introduction
The c-Abl non-receptor tyrosine kinase was identi®ed as the mammalian homolog of the v-Abl oncogene from the Abelson murine leukemia virus (Go et al., 1980) . Mammalian c-Abl and the c-abl-related gene (Arg) product (Kruh et al., 1990) are members of a family of cellular proteins that exhibit structural similarities in the sea urchin, fruit¯y and nematode (Goddard et al., 1986; Henkemeyer et al., 1988; Moore and Kinsey, 1994) . The c-abl gene is ubiquitously expressed in mammalian cells and encodes two 145 kDa isoforms as a result of alternate splicing of the two ®rst exons (Ben-Neriah et al., 1986) . The Nterminal half of c-Abl contains SH3, SH2 and catalytic domains. The C-terminus includes nuclear localization signals, DNA-binding domains and actin-binding domain (Van Etten et al., 1994; Wen et al., 1996) . Targeted disruption of c-Abl in mice is associated with birth of runted animals which die as neonates with defective lymphopoiesis (Schwartzberg et al., 1991; Tybulewicz et al., 1991) .
Ionizing radiation (IR) and certain other genotoxic agents activate c-Abl (Kharbanda et al., 1995a Liu et al., 1996) . IR induces the formation of a complex involving c-Abl, the DNA-dependent protein kinase (DNA-PK) and Ku antigen . DNA-PK is activated by DNA damage and in turn phosphorylates and activates c-Abl . Other studies have shown that c-Abl associates with the product of the ATM gene and that ATM activates c-Abl in the response to IR (Baskaran et al., 1997; Shafman et al., 1997) . Overexpression of c-Abl induces arrest of cells in G1 phase by a p53-dependent mechanism (Goga et al., 1995; Mattioni et al., 1995; Sawyers et al., 1994) . Moreover, DNA damage induces binding of c-Abl to p53 and contributes to p53-dependent G1 arrest (Yuan et al., 1996a,b) . c-Abl also functions upstream as an inhibitor of PI 3-kinase (Yuan et al., 1997b) and as an activator of SAPK and p38 MAPK (Kharbanda et al., 1995a,b; Pandey et al., 1996) in the response to DNA damage. Thus, certain insights are available regarding the upstream activators and downstream eectors of cAbl activation in the DNA damage response.
The present studies demonstrate that c-Abl interacts with protein kinase C d (PKCd). Of the 12 known PKC isoforms (Nishizuka, 1992 (Nishizuka, , 1995 , the ubiquitously expressed PKCd ) is unique as a substrate for tyrosine phosphorylation (Li et al., 1994a) . Whereas activation of the PDGF (Li et al., 1994b) or epidermal growth factor (Denning et al., 1996) receptors and transformation by Ras (Denning et al., 1993) or v-Src results in tyrosine phosphorylation of PKCd, the eects of such phosphorylation on the serine/threonine kinase activity of PKCd have been con¯icting (Li et al., 1996) . Our ®ndings demonstrate that c-Abl phosphorylates PKCd in the response of cells to IR treatment. The results also demonstrate that c-Abl activates PKCd.
Results and discussion
Whereas previous studies have demonstrated that c-Abl and PKCd are both individually involved in the induction of apoptosis (Emoto et al., 1995 Ghayur et al., 1996; Yuan et al., 1997a) , we sought to investigate potential interactions between these proteins. Immunoblot analysis of anti-c-Abl immunoprecipitates from MCF-7 cells with antibodies against PKCa, PKCb and PKCg demonstrated no detectable reactivity ( Figure 1a and data not shown). By contrast, anti-c-Abl immunoprecipitates exhibited reactivity with anti-PKCd at an apparent molecular weight of *80 kDa (Figure 1b) . Similar ®ndings were obtained after IR treatment (Figure 1b ). In the reciprocal experiment, analysis of anti-PKCd immunoprecipitates with anti-c-Abl con®rmed constitutive binding of these proteins that was comparable in irradiated cells ( Figure  1c) . Similar results were obtained in diverse cell types that, in addition to MCF-7 cells, include U-937 and HL-60 myeloid leukemia cells and mouse ®broblasts (data not shown). These ®ndings thus support the constitutive association between c-Abl and PKCd.
The association between c-Abl and PKCd was further analysed by incubating cell lysates with a GST fusion protein prepared from the Abl SH3 domain. Adsorbates obtained with GST-Abl SH3, but not GST, revealed binding of PKCd ( Figure 2a) . As a control, there was no detectable binding of PKCd to the N-terminal domain of the Grb2 adaptor protein or to the Abl actin binding domain (GST-Abl ABD) ( Figure 2a ). Moreover, incubation of cell lysate with GST-PKCd con®rmed the association with c-Abl (Figure 2b ). The c-Abl SH3 domain binds to prolinerich sequences with the PXXP consensus (Feller et al., 1994; Ren et al., 1994) . The presence of potential sequences for c-Abl binding in the C-terminal region of human PKCd (PHYP, PFRP) suggested that there may be a direct interaction. To determine whether the interaction between c-Abl and PKCd is direct, GST and GST-Abl SH3 were incubated with puri®ed recombinant PKCd. Analysis of adsorbed protein by immunoblotting with anti-PKCd demonstrated direct binding of these proteins (Figure 2c ).
To determine whether c-Abl phosphorylates PKCd in vitro, heat-inactivated and kinase-active recombinant c-Abl were incubated with equal amounts of GSTPKCd and [g-32 P]ATP. Autoradiography of the reaction products demonstrated phosphorylation of GST-PKCd by kinase-active c-Abl ( Figure 3a ). As shown previously (Kharbanda et al., 1995b) , c-Abl exhibited no detectable phosphorylation of GST (data not shown). To de®ne the eects of c-Abl on PKCd activity, GST-PKCd was incubated with heat-inactivated or kinase-active c-Abl and the PKC peptide (PLSRTLSVAAK) substrate. Whereas c-Abl alone had no eect on phosphorylation of the PKC substrate (data not shown), incubation of kinase-active, but not heat-inactivated, c-Abl with GST-PKCd increased PKCd activity (Figure 3b ). These ®ndings provided support for c-Abl-mediated phosphorylation and activation of PKCd in vitro.
To determine whether c-Abl regulates PKCd in vivo, we irradiated MCF-7 cells expressing the null pSR vector or the dominant negative, kinase-inactive c- (Figure 4b ). Whereas these ®ndings support c-Abl-dependent phosphorylation of PKCd, we performed subcellular distribution studies to assess the eects of irradiation on translocation of PKCd. IR treatment had no apparent eect on PKCd associated with the cell membrane (Figure 4c ). However, irradiation of MCF-7/pSR cells was associated with translocation of PKCd to the nucleus ( Figure 4c ). As a control, immunoblotting with anti-IkBa showed that the nuclear preparations were not contaminated with cytoplasmic proteins (data not shown). Importantly, there was no detectable nuclear translocation of PKCd in the irradiated MCF-7/c-Abl(K-R) cells (Figure 4c ). These ®ndings collectively indicate that IR induces tyrosine phosphorylation and activation of PKCd by a c-Abl-dependent mechanism. The initial observation that c-Abl is activated in the cellular response to DNA damage provided certain insights into a potential functional role for this tyrosine kinase (Kharbanda et al., 1995b) . More recent work demonstrating that c-Abl is activated by DNA-PK and ATM has supported involvement of c-Abl-dependent pathways in transducing DNA damage to informational signals that aect cell behavior (Baskaran et al., 1997; Kharbanda et al., 1997; Shafman et al., 1997) . The present studies identify PKCd as a novel eector of c-Abl-dependent signaling in the genotoxic stress response. The results demonstrate that c-Abl phosphorylates and activates PKCd in vitro. IR-induced activation of c-Abl in cells was also associated with tyrosine phosphorylation of PKCd and the translocation of PKCd to the nucleus. Diverse stimuli have been shown to induce nuclear translocation of PKCa, b and g (Olson et al., 1993) ; however, the present ®ndings represent the ®rst demonstration that PKCd is translocated to the nucleus. Sequences resembling the bipartite nuclear localization motifs found in certain nuclear proteins (Dingwell and Laskey, 1991) are present in PKCd near the catalytic domain (amino acids 378 ± 399). Thus, c-Abl-mediated phosphorylation of PKCd may result in both allosteric activation and unmasking of otherwise cryptic nuclear localization sequences.
Other studies have shown that, in concert with a potential tumor suppressor function , PKCd is involved in the induction of growth arrest (Watanabe et al., 1992) and apoptosis (Emoto et al., 1995 Ghayur et al., 1996) . Treatment of cells with IR and other DNA-damaging agents results in proteolytic activation of PKCd (Emoto et al., 1995 . Cleavage of PKCd in the V 3 region is mediated by caspase 3 and results in a 40 kDa catalyticallyactive fragment (Ghayur et al., 1996) . Of potential relevance to the present work is the demonstration that activation of PKCd can induce apoptosis (Ghayur et al., 1996) . In this context, transient transfection studies with wild-type, but not kinase-inactive, c-Abl have also demonstrated induction of apoptosis (Yuan et al., 1997a) . Moreover, Abl 7/7 cells and cells that stably express kinase-inactive c-Abl exhibit resistance to IRinduced apoptosis (Yuan et al., 1997a) . Thus, both cAbl and PKCd have been linked to induction of apoptosis by DNA-damaging agents. The functional interaction between activated c-Abl and PKCd in the IR response as shown in the present studies may therefore potentiate the pro-apoptotic eects of c-Abl through induction of PKCd activity.
Materials and methods

Cell culture
Human MCF-7 breast cancer cells were grown in Dulbecco's modi®ed Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum . Null pSRaMSVtkneo and pSRaMSV c-Abl K(290)Rtkneo vectors were stably expressed in MCF-7 cells by transfection and selection in G418 . Human U-937 and HL-60 myeloid leukemia cells (ATCC, Rockville, MD) were grown as described (Kharbanda et al., 1995c) . Irradiation was performed at room temperature using a Gammacell 1000 (Atomic Energy of Canada) under aerobic conditions with a 137 Cs source emitting at a ®xed dose rate of 0.76 Gy min 71 as determined by dosimetry.
Immunoprecipitation and immunoblot analysis
Cell fractionation and immunoprecipitations were performed as described (Kharbanda et al., 1995b . Soluble proteins were incubated with anti-c-Abl (Ab-3; Oncogene Science) or anti-PKCd (C-20; Santa Cruz Biotechnology) and precipitated with protein A-Sepharose for an additional 1 h. The immune complexes were washed with lysis buer (1 mM EDTA, 1 mM EGTA, 10 mM bglycerophosphate, 2 mM MgCl 2 , 10 mM KCl, 1 mM sodium orthovanadate, 1 mM DTT and 10 mg/ml each of pepstatin, leupeptin and aprotinin), separated by electrophoresis in SDS/polyacrylamide gels and then transferred to nitrocellulose paper. Filters were incubated with anti-PKCd, antic-Abl, anti-P-Tyr (4G10, Upstate Biotechnology Inc.) or anti-IkBa (06-495; Upstate Biotechnology, Inc.). The antigen-antibody complexes were visualized by enhanced chemiluminescence (ECL; Amersham).
Fusion protein binding assays
GST, GST-Abl SH3 , GST-Grb2 N.SH3 (SC-4036; Santa Cruz Biotechnology), GST-Abl ABD (actin-binding domain; amino acids 1050 ± 1130) and GST-PKCd were puri®ed by anity chromatography using glutathione-Sepharose beads. Cell lysates were incubated with immobilized GST or GST-fusion protein for 2 h at 48C. The resulting protein complexes were separated by SDS/polyacrylamide gel electrophoresis and subjected to immunoblot analysis with anti-PKCd or antic-Abl.
Phosphorylation of PKCd
Recombinant kinase active c-Abl was prepared from baculovirus-infected insect cells (Mayer and Baltimore, 1994) . GST-PKCd was incubated with heat-inactivated (HI) or kinase-active c-Abl and [g-32 P]ATP. The reaction products were analysed by SDS/polyacrylamide gel electrophoresis and autoradiography.
PKCd kinase assays
GST-PKCd was incubated with heat-inactivated or kinaseactive c-Abl and ATP. The GST-PKCd was then isolated by incubation with glutathione-Sepharose beads and resuspended in kinase buer (50 mM HEPES, pH 7.0, 10 mM MnCl 2 , 10 mM MgCl 2 , 1 mM DTT). PKC assays were performed as described (Cat. #V5330; Promega) using the PLSRTLSVAAK peptide as substrate. Reaction products were analysed by agarose gel electrophoresis and¯uorescence detection.
Transient transfection
MCF-7 cells were cotransfected with 8 mg pSVb-PKCd vector (Ghayur et al., 1996) and 8 mg (i) null pSRaMSVtkneo; (ii) pSRaMSV c-Abltkneo; or (iii) pSRaMSV cAbl(K-R)tkneo (Sawyers et al., 1994) by Lipofectamine (GIBCO-BRL). The cells were harvested 48 h after transfection. Lysates subjected to immunoprecipitation with anti-PKCd were analysed by immunoblotting with anti-P-Tyr and anti-PKCd.
